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Overview
AMPs And their MiCs
Antimicrobial peptides (AMPs) are a class of 
antibiotics that is part of the innate immune 
system of virtually all organisms. This is a 
broadly defined class, with many common 
characteristics – and many exceptions to 
those. The reader will find detailed reviews 
of such characteristics and proposed sub-
classifications of the AMPs (see Yeaman 
and Yount, 2003, for example) but, very 
generally, these are short, cationic peptides 
that kill bacteria (sometimes only Gram-
positives, sometimes only Gram-negatives, 
sometimes both) at concentrations typically 
in the low micromolar range. The clinical 
interest of some AMPs stems from a low 
toxicity to mammalian cells, together with 
the fact that bacterial resistance to these 
antibiotics seems inherently difficult to 
acquire (Bell and Gouyon, 2003; Perron 
et al., 2006).
Of importance to the discussion later 
on is the method and conditions through 
which MICs are established for a given 
peptide against a given bacterial strain. A 
widely adopted protocol to this end is the 
one provided by the lab of Robert Hancock 
(Giacometti et al., 2000); it consists in mon-
itoring the growth of quite dilute bacterial 
suspensions after administration of differ-
ent peptide doses. The MICn is then defined 
as the peptide concentration that causes a 
reduction of n% in growth relative to con-
trol (MIC
50
 and MIC
90
 being the most com-
monly reported) after a set time interval.
LiPOsOMes As biOPhysiCAL MeMbrAne 
MOdeLs
AMPs make good test subjects for biophysi-
cal methodologies. Accounting for this is the 
peptides’ small size, and the ease with which 
one can influence their molecular-level 
properties simply by changing the amino 
acid sequence. In addition, an early rec-
ognition of the importance of membrane 
interaction and disruption for the action 
of AMPs (Lehrer et al., 1989) allowed the 
coupling of the mature field of membrane 
biophysics to study the latter.
With the exception of certain methodol-
ogies, lipid vesicles have been the preferred 
biophysical model for mimicking biologi-
cal membranes – bacterial or otherwise 
(Matsuzaki et al., 1995; Willumeit et al., 
2005). In the three decades of AMP studies 
a wealth of biophysical data has been col-
lected from these peptide-vesicle systems. 
These data include structural features – such 
as peptide structuring, oligomerization, 
depth of insertion, etc. – thermodynamic 
properties – such as peptide-membrane 
affinity and functional aspects – typically 
membrane disruption events such as pora-
tion or lysis, but also peptide translocation 
and lipid charge neutralization (Shai, 1999).
MeMbrAne disruPtiOn And high PePtide-
tO-LiPid rAtiOs
It came to our attention, first from our 
own studies and then from others’ reports 
(Melo et al., 2009), that several membrane 
disruptive events were often observed at 
concentrations where the vesicle membrane 
would be almost completely covered by the 
peptide–peptide-to-lipid (P:L) ratios higher 
than 1:25. It is common to read remarks 
on the unphysiological character of results 
obtained using too high such ratios (Zhang 
et al., 2001; Hancock and Rozek, 2002; 
Nicolas, 2009) but a sound basis for this 
assumption is yet to be provided.
It is easy to see the reasons behind the 
intuitive notion of the unphysiological 
character of high P:L ratios: first, peptides 
are nanometer-scale entities, typically 
 present at micromolar concentrations, that 
seem impossible to exist in enough numbers 
to cover a (relatively) macroscopic entity 
such as a bacterium. Second, laboratory 
research often requires the use of peptide 
and lipid concentrations equivalent to 
many times those present in MIC assays; 
this further contributes to the notion that 
any events thus observed are only achievable 
with the extreme concentrations available 
in vitro, even though the bound P:L ratios 
may actually be the same as in much more 
dilute conditions.
Conversely to these considerations, 
already in 2000 Tossi et al. had pointed out 
the great excess of peptide to bacterial lipids 
at typical AMP MIC conditions. We further 
developed that consideration by taking into 
account measured affinities of AMPs to 
bacterial membrane mimics. From there 
we arrived at expected peptide-to-lipid 
ratios in the bacterial membrane that fall 
precisely in the range where liposomal dis-
ruption is commonly observed (Melo et al., 
2009, 2011), and that many insist on calling 
“unphysiological.” Furthermore, attempts 
at directly quantifying bacterium-bound 
AMPs – though scarce – again point to very 
high degrees of bacterial surface coverage 
(Steiner et al., 1988; Albrecht et al., 2002; 
Tran et al., 2002; Ding et al., 2003).
FrOM biOPhysiCs tO biOLOgy
bACteriAL MeMbrAne – hOw MuCh OF it is 
there?
One of the main issues when trying to assess 
the validity of high P:L ratios comes from 
the fact that it is not readily measurable how 
much membrane a bacterial suspension 
has available for interaction. To estimate 
a peptide-to-lipid proportion Tossi et al. 
needed to find an approximate value for 
this amount of available lipid. They did so 
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using a geometrical approach, taking into 
account the average areas of the bacterial 
surface and of a membrane phospholipid. 
After factoring in the bacterial titer a lipid 
concentration of 25 nM was estimated 
(Tossi et al., 2000). Blazyk et al. (2001) later 
followed a similar reasoning, estimating a 
value of 66 nM. We carried out a different 
calculation, using the bacterial dry weight, 
its fraction that are phospholipids, and an 
average phospholipid mass. The value of 
58 nM to which we arrived (Melo et al., 
2011) is in good agreement with the two 
previous estimates.
The bottom line from these numbers is 
that under MIC assay conditions membrane 
lipids are present in concentrations in the 
range of tens of nanomolars, whereas there 
are about two orders of magnitude more 
peptide available to bind it.
hOw MuCh PePtide binds?
Not all the peptide in solution will bind the 
available membrane lipids, as binding is a 
reversible process subject to an equilibrium 
constant (Santos et al., 2003). How much 
peptide does bind can be quantitatively cal-
culated since those equilibrium constants 
are often measured, usually in the form of 
membrane binding or partition (K
p
) con-
stants. We have shown (Melo et al., 2011) 
that typical partition constants for AMPs, 
though quite high, will drive less than 1% 
of the total peptide to the membrane; this 
is still enough, however, for a typical AMP 
to reach P:L ratios between 1:20 and 1:10 
at global concentrations close to their MIC. 
These calculations provide theoretical sig-
nificance to the aforementioned observa-
tions of disruptive events at high P:L ratios. 
This is not to say that all AMPs only become 
active at high degrees of membrane cov-
erage, but it is plausible to say that many 
might behave thus, and therefore that no 
observations at high P:L ratios should be 
discarded.
bridging the gAP: MiC PrediCtiOn
The simple relationships that were used to 
establish the plausibility of high P:L ratios 
could be used in the reverse direction: by 
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1.2 MIC estimation
a,b by eq. 1 from different parameters of BP100 
Kp
P:L* Panel A 
(P:L* 1) 
Panel A 
(P:L* 2) 
Panel B Neutralization 
assumptionc  
 Panel Ad  3.18 ± 1.00 1.91 ± 0.63 3.39 ± 1.03 3.18 ± 0.96  
 Panel C  2.58 ± 0.49 1.55 ± 0.33 2.75 ± 0.46 2.58 ± 0.43  
Direct MIC estimatee 1.84 ± 0.51    
aValues in M. 
bA γ L value of 0.763 M-1 was used. 
cEstimated P:L* of 1:9 as per eq. 2 for BP100 in a 2:1 POPG:POPC system. 
dOnly the Kp value from the multiple-state fit was used. 
eEstimate from the intercept of the regression in panel B. 
 
Figure 1 | Different experimental methods to determine Kp and P:L* for a 
peptide-vesicle system, exemplified with the peptide BP100 with 
liposomes of 2:1 anionic-to-zwitterionic lipid constitution (Ferre et al., 
2009). (A) Partition curve with an obvious deviation from hyperbolic behavior 
at low lipid concentrations; a Kp of (39.3 ± 14.4) × 10
3 was obtained from a 
simple fit to the filled data points (Ferre et al., 2009); a fit to all data points was 
possible by assuming the coexistence of different bound states (Melo and 
Castanho, 2007), yielding a Kp of (45.8 ± 13.8) × 10
3 and two P:L* values, of 
0.111 ± 0.01 and 0.067 ± 0.008, respectively (indicated by arrows). 
(B) Membrane saturation points obtained at different peptide and lipid 
concentrations; the linear fit (Ferre et al., 2009) yielded a P:L* of 0.118 ± 0.003; 
the intercept of (1.84 ± 0.51) μM is a direct estimate of the MIC as per Eq. 1 
(Melo et al., 2011). (C) Normalized ζ-potential measurements from where a Kp 
of (56.4 ± 9.4) × 103 was extracted (Freire et al., 2011). (D) Summary of the 
possible MIC calculations, by Eq. 1, from different parameters (estimated – 
see Eq. 2 – or from panels A–C); these overlap nicely with the 2.5–7.5 μM 
range where BP100 is active against different Gram-negatives (Ferre et al., 
2009; Alves et al., 2010).
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then boost the affinity for the anionic bac-
terial membrane. However, peptide charge 
density is a double-edged sword: too much 
of it will cause surface neutralization at low 
bound concentrations – perhaps too low to 
trigger activity (Alves et al., 2010) – and sub-
sequent peptide binding will no longer be 
favored after the electrostatic driving forces 
have been quenched. Given this, it may be 
the case that typical AMPs have evolved to 
have the highest charge density that does 
not compromise their accumulation in the 
membrane. Surface charge neutralization at 
membrane disruption would then arise not 
from a cause-effect relationship but rather 
as a consequence of optimal antibacterial 
peptide properties.
COnCLusiOn
The path that bridges biophysical data with 
macroscopic physiological observations is 
paved with assumptions that are sometimes 
taken for granted. We started this work by 
challenging the notion of unphysiologi-
cally high AMP P:L ratios. By then taking a 
modeling approach we not only demystified 
the issue, but also achieved new perspec-
tives on AMP action that ultimately led to 
a predictive model – interestingly, one that 
does not require specifically high P:L ratios 
and is therefore even compatible with more 
conservative views.
Just as there are exceptions to almost any 
characteristic a typical AMP is said to pos-
sess, so do we expect there to be several cases 
of peptides that will not conform to our pre-
dictions. At any rate, a simple new approach 
to AMP action is provided that we hope will 
spur novel developments on the field.
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peptide vs. lipid relationship, whereas the 
intercept will be itself a direct estimate of 
the MIC (this is so because the limit of zero 
lipid concentration parallels the very low 
lipid concentration in a MIC assay; Melo 
et al., 2011).
Neutralization assumption
For some peptides it may be plausible to 
assume that P:L* coincides with, or is trig-
gered by, electrostatic neutralization of the 
membrane (Ferre et al., 2009). In the case 
of a one-to-one peptide-lipid charge neu-
tralization it can be seen that P:L* will be 
given by:
*P:L =
⋅f z
z
C L
P
 (2)
where f
C
 is the fraction of charged lipids, 
z
L
 the absolute formal charge per charged 
lipid, and z
P
 the absolute formal charge on 
the peptide (assuming peptide and lipid 
charges have opposite signs; extra terms 
must be introduced in case of multiple 
lipids of different charges). This assump-
tion provides an easy shortcut to a poten-
tially relevant threshold, if no other data are 
available.
Equation 1 is not only simple and 
straightforward to use, but was also suc-
cessfully applied to data for peptides BP100 
(Figure 1D) and omiganan (Melo et al., 
2011). Furthermore, it should be remarked 
that although the involved research was 
spurred by such observations the applica-
bility of Eq. 1 does not depend on P:L* actu-
ally being very high. Nor is Eq. 1 restricted 
to bacterial death: it may be applicable to 
systems with relevant membrane threshold 
events, such as hemolysis (Melo et al., 2011).
iMPrOving the MiCs OF AMPs
It is interesting to analyze the issue of AMP 
activity optimization under the light of 
Eq. 1. It can be seen that lower MICs can 
be achieved either by having peptides with 
a low P:L* (i.e., requiring very little mem-
brane-bound concentration to trigger bacte-
ricidal action) or with a high K
p
 (i.e., having 
a very strong affinity for the membrane). 
Designing peptides with lowered P:L* is not 
straightforward as the cooperative mecha-
nisms involved in disruption are not yet fully 
understood. On the other hand, improving 
K
p
 is an apparently easier task: one would 
need only increase the charge density on 
the peptide as much as possible, which will 
knowing a critical P:L ratio at which an 
AMP becomes disruptive against a given 
membrane model we can calculate the 
global AMP concentration required for it 
to reach a similar P:L ratio in a bacterium. 
This concentration will be a MIC estimate. 
A very simple equation (Melo et al., 2011) 
summarizes the relationship between MIC, 
critical P:L ratio (P:L*), and membrane 
affinity(K
p
):
MIC
P:L
L
=
⋅
∗
Kp γ  
(1)
where γ
L
 is the lipid molar volume, a known 
value for artificial lipid fluid bilayers (Chiu 
et al., 1999).
Equation 1 does require the determi-
nation of the P:L* and K
p
 parameters. We 
provide here a summary of methods to their 
determination using model membranes, as 
well as collected examples with the peptide 
BP100 in Figure 1:
Partition data
The value for K
p
 can be extracted from 
experiments where the fraction of bound 
peptide is determined at different concen-
trations of lipid (Figure 1A; see Santos 
et al., 2003, for an overview on K
p
 extrac-
tion from these curves). Oftentimes data 
points at low lipid concentrations – the 
conditions at which the peptide is most 
concentrated in the membrane – will devi-
ate from the expected hyperbolical rela-
tionship. By fitting a model that accounts 
for different membrane-bound states 
(Melo and Castanho, 2007) a value for K
p
 
and two critical P:L ratios can be recovered 
(Figure 1A).
Other setups similar to the described 
above, but not necessarily involving a lipid 
titration, can be used to determine K
p
: 
isothermal titration calorimetry (Bastos 
et al., 2008) is an accurate alternative; 
peptide quantification after separation 
by ultracentrifugation has also been suc-
cessfully applied (Cirac et al., 2011); and 
a method has been recently put forth that 
allows K
p
 extraction from ζ-potential data 
(Figure 1C; Freire et al., 2011).
Threshold points
There is a linear relationship between 
global peptide and lipid concentrations for 
a threshold point to be reached (Figure 1B; 
Pott et al., 1998; Melo and Castanho, 2007). 
P:L* can be recovered from the slope of this 
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